Fundz

Rivus Pharmaceuticals, Inc. reported raising $34.5 Million in an initial SEC Form D filing, from an offering of $35 Million

PRIVATEOct 04, 2021$34.5M of $35M raised

Amount Raised

$34.5 Million

$34.5 Million sold, per SEC Form D (first sale Oct 4, 2021)

Round Type

Venture

CharlottesvilleBiotechnologyHealth Care

Quick answer

Rivus Pharmaceuticals raised $34.5 Million in a funding round, dated October 4, 2021. Rivus Pharmaceuticals is based in Charlottesville, Virginia, United States.

How much did Rivus Pharmaceuticals raise?
Rivus Pharmaceuticals raised $34.5 Million in a funding round on October 4, 2021.
What does Rivus Pharmaceuticals do?
Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators..
Where is Rivus Pharmaceuticals based and how big is it?
Rivus Pharmaceuticals is based in Charlottesville, Virginia, United States. Fundz records about 27 employees.
Who are the decision-makers at Rivus Pharmaceuticals?
Fundz holds 1 contact at Rivus Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Rivus Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Cardiff Oncology raised $15M on November 18, 2021.
  • VERTOS MEDICAL INC raised $17M on November 18, 2021.
  • Novabay raised $15M on November 17, 2021.
  • Ncardia raised $60M (Funding Round) on November 16, 2021.
  • Deka Biosciences, Inc. raised $20M (Series A) on November 16, 2021.
  • Geneoscopy raised $105M (Funding Round) on November 16, 2021.

Who to call at Rivus Pharmaceuticals, and when

A new round usually means Rivus Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Rivus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rivus Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rivus Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rivus Pharmaceuticals

Location

Charlottesville, Virginia, United States

About

Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rivus Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Rivus Pharmaceuticals's next move

See what Strategic adds

Rivus Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.